Emerging technologies to increase ligand binding assay sensitivity
about
Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesMultitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques.HIV-1 latent reservoir: size mattersUltrasensitive bioanalysis: current status and future trends.Application of multiplex immunoassay technology to investigations of ocular disease.Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.Selecting analytical biomarkers for diagnostic applications: a first principles approach.Development of a plug and play ImmunoPCR technique for the analysis of biomolecules.3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysis.Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagents.First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.Bioanalytical challenges and improved detection of circulating levels of IL-13.
P2860
Q26770708-80FDC69F-DA1A-4D91-B4FB-3602B0DFC77FQ30391340-F4505CD8-9231-4D76-84A4-736AC79FCCD6Q34486159-2E3A6CB4-6840-489F-A5FD-C323453CE830Q38649553-98A13A37-14B1-41B2-AE69-669EBE7F725BQ38685682-4301DE21-7612-4294-A7A9-4D5E838FF29CQ38941639-9D302CFA-0A5E-4528-BAC6-F13D61ED329DQ47225640-70300669-09D9-44FF-9A12-AB83448D5E08Q48265538-D23DFDFE-BC56-4AA9-BF71-E381DC332750Q50098404-D5F471BB-6915-47C6-A5B5-D7CD007FE2CEQ50123752-749D0061-2439-4AD9-8D95-B08D8C4F5AB6Q51181142-1CBC7854-B6C4-44BD-BE79-5CB58B74EED9Q51445222-3C231E6D-5905-46FA-8EB5-A89976B7E3AEQ52645845-19A95718-76CD-4A6D-9A6F-2E5DF1543AD9Q53186302-B059D8DE-C6C0-4D8E-BC68-C2F519DB3192
P2860
Emerging technologies to increase ligand binding assay sensitivity
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging technologies to increase ligand binding assay sensitivity
@ast
Emerging technologies to increase ligand binding assay sensitivity
@en
Emerging technologies to increase ligand binding assay sensitivity
@nl
type
label
Emerging technologies to increase ligand binding assay sensitivity
@ast
Emerging technologies to increase ligand binding assay sensitivity
@en
Emerging technologies to increase ligand binding assay sensitivity
@nl
prefLabel
Emerging technologies to increase ligand binding assay sensitivity
@ast
Emerging technologies to increase ligand binding assay sensitivity
@en
Emerging technologies to increase ligand binding assay sensitivity
@nl
P2093
P2860
P1433
P1476
Emerging technologies to increase ligand binding assay sensitivity
@en
P2093
Alison Joyce
Alvydas Mikulskis
Marianne Scheel Fjording
Mark Spengler
Saloumeh K Fischer
Tong-Yuan Yang
Yao Zhuang
P2860
P2888
P304
P356
10.1208/S12248-014-9682-8
P407
P577
2014-10-18T00:00:00Z
P5875
P6179
1019872776